id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-326354-fhafg41x	Pesavento, Raffaele	The hazard of (sub)therapeutic doses of anticoagulants in non‐critically ill patients with Covid‐19: the Padua province experience	2020-07-21		.txt	text/plain	2835	136	40	As available information on the benefit/risk profile of this approach is still lacking, we retrieved information from a broad Accepted Article number of consecutive patients with non-critical COVID-19 who had been admitted to two medical wards and had been prescribed variable doses of antithrombotic drugs according to the physicians' perception of the thromboembolic risk. The increasing awareness that low-dose anticoagulants may be ineffective for prevention of thrombotic complications in the course of COVID-19, including the development of micro-thrombosis in the lung vessels, has induced several clinicians to consider the use of sub-therapeutic or even therapeutic doses of antithrombotic agents in all admitted patients, challenging their hemorrhagic potential [13, 30] . Not surprisingly, the incidence of major or clinically relevant bleeding complications occurring during hospitalization was remarkably higher in patients treated with (sub)therapeutic than in those receiving preventive doses of antithrombotic drugs.	./cache/cord-326354-fhafg41x.txt	./txt/cord-326354-fhafg41x.txt